 Home > Active Ingredient News > Blood System > Blood Advances: Elderly patients with follicular lymphoma should not be disqualified for treatment because of their age

Blood Advances: Elderly patients with follicular lymphoma should not be disqualified for treatment because of their age

 Last Update: 2021-03-30
 Source: Internet
 Author: User

Tags

tree age rings

author

united states jobs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

FL is one of the most common painless non-Hodgkin’s lymphomas .

Lymphoma

There are limited data on the clinical features and prognosis of elderly follicular lymphoma (FL).

The study concluded that the early disease prognosis of elderly FL patients is similar to that of younger patients, and that age alone should not disqualify elderly FL patients from standard treatment.

The early disease prognosis of elderly FL patients is similar to that of younger patients, and only age should not disqualify elderly FL patients from standard treatment.

There was no difference in the results of CR24, CR30 or PFS24 between patients older than 70 years old and patients less than 70 years old.

The author believes that age> 70 years is an important predictor of OS and PFS, because patients who have not progressed have a higher mortality rate .

Age> 70 years is an important predictor of OS and PFS, because patients who have not progressed have a higher mortality rate

references:

Casulo C, Dixon JG, Ou FS, Hoster E, Peterson BA, Hochster HS, Brice P, Ladetto M, Hiddemann W, Marcus R, Kimby E, Herold M, Nielsen T, Morschhauser F, Rummel M, Hagenbeek A, Vitolo U , Salles GA, Shi Q, Flowers CR.

org/bloodadvances/article/5/6/1737/475533/Outcomes-of-older-patients-with-follicular">https://ashpublications.

org/bloodadvances/article/5/6/1737/475533/Outcomes-of-older-patients-with-follicular">https://ashpublications.
org/bloodadvances/article/5/6/1737/475533/Outcomes-of-older-patients-with-follicular https://ashpublications.
org/bloodadvances/article/5/6/1737/475533 /Outcomes-of-older-patients-with-follicular leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

SULODEXIDE 99% Almost White Powder Dideu-01112 Dideu

CAS No.: 57821-29-1

Pharmacy Grade

$61.76/G EXW

High Quality GMP / FDA Certificated Liraglutide Powder CAS 204656-20-2 Liraglutide

CAS No.: 204656-20-2

Pharmacy Grade

$30.00/G FOB

Heparin sodium 9041-08-1 vials safe delivery

CAS No.: 9041-08-1

Pharmacy Grade

$1/G EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.